Charles G Mullighan is an expert in Hematology at St. Jude Children's Research Hospital (United States). As of October 2026, ScienceLeadR ranks Charles G Mullighan in the top 1% of experts worldwide for Leukemia, Lymphoproliferative Disorders and Lymphoma. Charles G Mullighan has authored 723 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 3,467 (community average: 125). How the SLR is computed.

LeadR Profile

Charles G Mullighan St. Jude Children's Research Hospital United States
3 467 ScienceLeadR Reputation 3467
Network Map

Hematology

Subspecialties: Oncology - Genetics - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Charles Mullighan is a member (Professor) in the Department of Pathology and Senior Deputy Director of the Comprehensive Cancer Center at St Jude Children’s Research Hospital. He trained as a hematologist in Adelaide with doctoral studies in Oxford England, and joined St Jude in 2004. His research program uses integrated genomic analysis, experimental modelling and drug development to define the drivers and vulnerabilities of acute leukemia. His work has defined the genetic basis of multiple new subtypes of leukemia, and these advances have entered the clinic as new diagnostic and therapeutic approaches. He is the recipient of awards including a National Cancer Institute Outstanding Investigator Award, the Meyenburg Prize for Cancer Research, the American Society of Hematology Dameshek Prize, the American Association for Cancer Research – St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research, and election to Fellowship of the Royal Society of London.

Organizations

Career arc: 1993 - 2026

Source: PubMed

St. Jude Children's Research Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 723

Citations

Citations: 56 795 1st author: 53 Last author: 146 Unique author: 22


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study.
PMID 42832396 — cells, precursor cell lymphoblastic leukemia-lymphoma, leukemia, drug therapy, therapeutics, enhancer elements, genetic, mutation, chemotherapy
Blood20260
Author Correction: Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia.
PMID 42711487 — histones, lysine
Nature Top journal20260
Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies.
PMID 42685004 — cells, precursor cell lymphoblastic leukemia-lymphoma, hematology, neoplasms, leukemia, cell line, polyamines, therapeutics, t-lymphocytes
Blood20260
Mapping the de-implementation of traditional diagnostic tests in pediatric acute lymphoblastic leukemia.
PMID 42676406 — precursor cell lymphoblastic leukemia-lymphoma, genomics, neoplasms, leukemia, cytogenetics
Front Oncol20260
Traumatic lumbar puncture at diagnosis in children and adolescents with acute lymphoblastic leukemia.
PMID 42538430 — precursor cell lymphoblastic leukemia-lymphoma, spinal puncture, leukemia, adolescent, diagnosis, punctures, child
Leukemia20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 4
N/A 2
Phase 2 2
Phase 2/Phase 3 1

By status:

Completed 6
Active not recruiting 2
Recruiting 1

By type:

Interventional 8
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 7

Main Topics

LeadR Networks

Main global connection map